| Literature DB >> 36051702 |
Ke Zhao1, Shilei Dong2,3,4, Wei Wang2,3,4.
Abstract
Objective: The purpose of this study was to explore the safe and most effective initiation time for the functional recovery of patients with peri-ankle fractures after surgery. Method: We searched electronic databases, including the Cochrane Library, Embase, PubMed and the reference lists of relevant articles published from inception to October 30, 2021. Two researchers independently performed literature screening and data extraction and evaluated the quality of the included literature using the Newcastle-Ottawa Scale. Network meta-analysis, including consistency testing, publication bias, and graphical plotting, was performed using Stata (v16.0).Entities:
Keywords: meta-analysis; peri-ankle fractures; periarticular fractures; postoperative functional recovery; rehabilitative exercise
Year: 2022 PMID: 36051702 PMCID: PMC9424660 DOI: 10.3389/fsurg.2022.911471
Source DB: PubMed Journal: Front Surg ISSN: 2296-875X
Figure 1Flow chart of the literature screening process RCT, randomized controlled trial; E, experimental group; C, control group; NA, Not available; lauge-hansen Se, lauge-hansen supination external rotation type; lauge-hansen Pe, lauge-hansen pronation- eversion; RT, rehabilitation training; WB, weight bearing AOFAS scores②VAS scores③total postoperative complication rates④DVT rates.
Basic characteristics and quality evaluation of the included studies.
| Study | Year | Country | Type of study | Sample size (E/C) | Type of fracture | Injury-operation | Initiation | Movement style | Outcomes | Follow-up |
|---|---|---|---|---|---|---|---|---|---|---|
| Egol K | 2000 | United Kingdom | RCT | 27/28 | Weber BC | NA | 2w/6w | RT | ① | 12w |
| Franke J | 2008 | Germany | RCT | 14/13 | Weber B | 5d/7d | 2d/6w | WB | ② | 10w |
| Dogra | 1999 | United Kingdom | RCT | 26/26 | Weber B | NA | 1d/2w | WB | ②③ | 12w |
| Anne M | 2015 | Australia | RCT | 106/108 | Weber ABC | NA | 1w/4w | RT | ①③ | NA |
| Christian JP | 2005 | Germany | RCT | 23/23 | Weber BC | NA | 1d/6w | WB | ③ | 12m |
| Diederik P | 2018 | Canada | RCT | 36/37 | Lauge-Hansen Se2,3,4 | NA | 10d/6w | WB | ③ | 1y |
| DiStasio | 1994 | United Kingdom | RCT | 25/31 | Weber BC | NA | 1w/6w | RT | ①③④ | 6m |
| Lee DH | 2012 | Korea | RCT | 40/41 | Weber BC | NA | 2w/6w | WB | ①② | 24–76m |
| Hendrik Jansen | 2018 | Germany | RCT | 22/22 | Weber BC | 7.4 h/8.9h | 1d/2d | RT | ①②④ | 12w |
| Kimmel LA | 2012 | Australia | RCT | 51/53 | Weber B | 54 h/50.9h | 1d/2d | RT | ③ | NA |
| Lehtonen | 2003 | United States | RCT | 50/50 | Weber AB | 30 h/25h | 1d /2w | WB | ①②③④ | 6w |
| Marius M | 2020 | Norway | RCT | 56/57 | Weber B | NA | 1d/1d | RT | ②③④ | 52w |
| Michael P | 2012 | United States | RCT | 19/107 | Lauge-Hansen Se2,4 | NA | 1d/8d | WB | ③ | 6w |
| Michael Z | 2021 | Germany | RCT | 25/20 | Weber ABC | 8 h/7h | 2d/6w | WB | ①③④ | 12m |
| Mihai V | 2007 | United Kingdom | RCT | 33/29 | Lauge-Hansen | NA | 1d/6w | RT | ①③④ | 12w |
| Min W | 2019 | China | RCT | 21/21 | Weber ABC | NA | 1d/5w | WB | ①② | 24m |
| Niloofar D | 2016 | Canada | RCT | 56/54 | Weber BC | 7 h/6.2h | 2w/6w | WB | ③ | 6W |
| Paolo C | 2019 | United Kingdom | RCT | 32/19 | Weber BC | NA | 1d/6w | WB | ③ | 12w |
| Pasquale F | 2009 | Italy | RCT | 22/22 | Weber ABC | NA | 1d/2w | RT | ①③④ | 10–14y |
| Torbjorn A | 1987 | Sweden | RCT | 25/28 | Lauge-Hansen Se4;Pe34 | NA | 1d /4w | WB | ③ | 6m |
| Stöckle U | 2000 | Germany | RCT | 20/20 | Weber ABC | NA | 2w/6w | RT | ①③ | 6w |
| William | 1989 | United States | RCT | 32/19 | Weber ABC | NA | 1d/6w | RT | ①③ | 10–14w |
| Li | 2013 | China | RCT | 22/21 | Weber ABC | NA | 1d/6w | RT | ①②③ | 12m |
| Liao | 2010 | China | RCT | 22/22 | Weber BC | NA | 1d/3w | RT | ①②③④ | 4.2y |
| Shi | 2020 | China | RCT | 40/49 | Weber ABC | NA | 1d/5w | WB | ①② | 24m |
Figure 2Green: Low risk of bias; yellow: unclear risk of bias; Red: high risk of bias.
Figure 3Reticulated evidence diagram of different rehabilitation intervention times after the operation. A: 1 day postoperatively, B: 2 days postoperatively, C: 1 week postoperatively, D: 8 days postoperatively, E: 10 days postoperatively, F: 2 weeks postoperatively, G: 3 weeks postoperatively, H: 4 weeks postoperatively, I: 6 weeks postoperatively, J: 9 weeks postoperatively, K: 12 weeks postoperatively, L: 6 months postoperatively, M: 12 months postoperatively, N: 24 months postoperatively. (A) Network evidence for AOFAS scores; (B) Network evidence for VAS scores; (C) Network evidence for total postoperative complication rates; (D) Network evidence for DVT rates.
Network meta-analysis results of AOFAS scores (RR, 95% CI).
| A | ||||||||
| 14.56 (−0.78,29.91) | B | |||||||
| 11.61 (−0.70,23.91) | −2.96 (−17.56,11.64) | F | ||||||
| 12.97 (−5.71,31.65) | −1.59 (−19.73,16.55) | 1.37 (−15.53,18.26) | I | |||||
| −2.24 (−23.20,18.72) | −16.80 (−41.01,7.40) | −13.85 (−36.93,9.24) | −15.21 (−41.68,11.25) | J | ||||
| −2.60 (−14.19,8.99) | −17.16 (−31.06,−3.26) | −14.20 (−27.26,−1.15) | −15.57 (−33.13,1.99) | −0.36 (−21.30,20.59) | K | |||
| −7.42 (−18.40,3.56) | −21.99 (−37.10,−6.87) | −19.03 (−32.51,−5.55) | −20.39 (−39.38,−1.40) | −5.18 (−27.52,17.16) | −4.82 (−16.40,6.76) | L | ||
| −10.77 (−23.54,2.00) | −25.33 (−43.25,−7.41) | −22.38 (−38.53,−6.23) | −23.74 (−44.79,−2.69) | −8.53 (−32.18,15.12) | −8.17 (−22.73,6.39) | −3.35 (−16.11,9.41) | M | |
| −9.44 (−24.51,5.64) | −24.00 (−43.86,−4.15) | −21.05 (−39.23,−2.86) | −22.41 (−45.15,0.32) | −7.20 (−32.34,17.94) | −6.84 (−23.95,10.27) | −2.02 (−17.09,13.05) | 1.33 (−14.19,16.85) | N |
Network meta-analysis results of VAS scores (RR, 95% CI).
| A | ||||||||
| 27.43 (18.69,36.17) | B | |||||||
| 1.09 (−2.86,5.05) | −26.33 (−35.47,−17.20) | F | ||||||
| 0.39 (−5.00,5.78) | −27.04 (−36.63,−17.44) | −0.70 (−7.02,5.62) | G | |||||
| 3.25 (−1.52,8.02) | −24.18 (−32.76,−15.60) | 2.16 (−2.67,6.98) | 2.86 (−3.28,8.99) | I | ||||
| −0.81 (−5.02,3.39) | −28.24 (−36.84,−19.64) | −1.91 (−7.52,3.71) | −1.21 (−7.05,4.64) | −4.06 (−10.01,1.88) | K | |||
| 1.10 (−2.36,4.56) | −26.33 (−35.42,−17.24) | 0.01 (−5.14,5.15) | 0.71 (−5.27,6.68) | −2.15 (−7.77,3.46) | 1.91 (−2.70,6.53) | L | ||
| 1.53 (−1.56,4.62) | −25.90 (−34.75,−17.05) | 0.43 (−4.38,5.25) | 1.14 (−4.34,6.61) | −1.72 (−6.86,3.41) | 2.34 (−1.88,6.56) | 0.43 (−3.04,3.89) | M | |
| 1.58 (−2.48,5.63) | −25.85 (−35.25,−16.45) | 0.48 (−5.09,6.06) | 1.18 (−5.21,7.58) | −1.67 (−7.69,4.34) | 2.39 (−2.92,7.70) | 0.48 (−3.68,4.63) | 0.05 (−4.01,4.11) |
|
Network meta-analysis results of postoperative complication rates (RR, 95% CI).
| A | ||||||||
| 0.66 (0.08,5.20) | B | |||||||
| 2.36 (0.21,26.20) | 3.58 (0.18,72.43) | C | ||||||
| 2.59 (0.23,29.36) | 3.92 (0.16,95.00) | 1.10 (0.04,33.48) | D | |||||
| 3.63 (0.21,63.39) | 5.50 (0.18,166.11) | 1.54 (0.04,57.45) | 1.40 (0.03,59.82) | E | ||||
| 2.08 (0.40,10.95) | 3.15 (0.27,36.95) | 0.88 (0.06,13.81) | 0.80 (0.04,15.25) | 0.57 (0.02,13.85) | F | |||
| 0.27 (0.05,1.56) | 0.40 (0.03,6.12) | 0.11 (0.01,2.24) | 0.10 (0.01,2.08) | 0.07 (0.00,2.12) | 0.13 (0.01,1.45) | G | ||
| 1.44 (0.15,13.41) | 2.18 (0.11,41.92) | 0.61 (0.07,5.71) | 0.56 (0.02,15.06) | 0.40 (0.01,14.05) | 0.69 (0.05,10.22) | 5.39 (0.31,93.04) | H | |
| 0.86 (0.28,2.60) | 1.30 (0.18,9.54) | 0.36 (0.04,3.74) | 0.33 (0.02,4.78) | 0.24 (0.01,4.04) | 0.41 (0.08,2.03) | 3.21 (0.40,25.89) | 0.60 (0.06,6.11) | I |
Network meta-analysis results of DVT rates (RR, 95% CI).
| A | ||||||
| 0.67 (0.08,5.44) | B | |||||
| 1.65 (0.05,51.46) | 2.47 (0.06,106.26) | C | ||||
| 1.42 (0.06,35.57) | 2.12 (0.06,80.36) | 0.86 (0.01,72.70) | E | |||
| 0.54 (0.07,4.21) | 0.81 (0.05,12.20) | 0.33 (0.01,13.90) | 0.38 (0.01,14.22) | F | ||
| 0.32 (0.03,2.95) | 0.48 (0.02,10.13) | 0.19 (0.00,11.57) | 0.22 (0.00,11.26) | 0.59 (0.03,12.11) | G | |
| 0.56 (0.15,2.01) | 0.83 (0.11,6.10) | 0.34 (0.01,8.17) | 0.39 (0.02,8.59) | 1.03 (0.14,7.33) | 1.75 (0.13,22.76) | H |